| Description | Licarbazepine (10,11-hydroxy-10,11 Dihydrocarbamezer) is the pharmacologically active metabolite of oxcarbazepine, a drug indicated for the treatment of partial seizures and bipolar disorders. |
| Synonyms | 10,11-hydroxy-10,11 Dihydrocarbamezer, 10,11-二氢-10-羟基卡马西平 |
| molecular weight | 254.28 |
| Molecular formula | C15H14N2O2 |
| CAS | 29331-92-8 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: 3 mg/mL (11.7 mM) |
| References | 1. Begas E , Tsakalof A , Dardiotis E , et al. Development and validation of a reversed-phase HPLC method for licarbazepine monitoring in serum of patients under oxcarbazepine treatment: HPLC method for licarbazepine monitoring in serum of patients[J]. Biomedical Chromatography, 2017, 31(9). 2. Binding of licarbazepine enantiomers to mouse and human plasma proteins[J]. biopharmaceutics & drug disposition, 2010, 31(5-6):0-0. |